CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients.

Motyka, Joanna; Kicman, Aleksandra; Kulesza, Monika; Lawicki, Slawomir

Motyka, Joanna; Kicman, Aleksandra; Kulesza, Monika; Lawicki, Slawomir.

Afiliación

Motyka J; Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Kicman A; Department of Aesthetic Medicine, Medical University of Bialystok, 15-267 Bialystok, Poland.
Kulesza M; Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Lawicki S; Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.

Cancers (Basel) ; 15(12)2023 Jun 08.

Article en En | MEDLINE | ID: mdl-37370728

Palabras clave

CXC chemokines; ELR-positive; breast cancer; concentration; diagnosis; expression; plasma; prognosis; serum

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google